Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
P2Y12 Inhibitor vs Aspirin in Colonoscopy
NCT06613191Phase 4Not yet recruiting
- Sponsor
- Ochsner Clinic Foundation
- Start
- Oct 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clopidogrel, prasugrel, ticagrelor in coronary artery disease (CAD), peripheral vascular disease (PVD), sponsored by Ochsner Clinic Foundation. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
clopidogrelprasugrelticagrelor
03
Conditions
coronary artery disease (CAD)peripheral vascular disease (PVD)
Beyond the preview
Go deeper on NCT06613191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06613191.